Consistency matters: Try to take your dose at around the same time each day. If you miss a dose, do not double up. Instead, contact your pharmacy or clinician for advice on what to do.

Taking the tablet

• Swallow whole with water.
• Do not crush or split unless the product instructions specifically allow it.
• Avoid handling crushed tablets (if tablets are broken or damaged) to reduce exposure to medication.

When to take with food

Food may affect absorption. Many patients are advised to take dasatinib consistently in relation to meals (for example, either always with food or always without food) depending on product information and clinical advice. Because recommendations may differ by product formulation and local guidance, follow the specific instructions given by your prescriber or pharmacist.

Tip: If your care team has advised a particular approach (for example, taking at the same time each day with or without food), maintain that routine and tell your pharmacist if your eating schedule changes.

Food Interactions (Including Stomach Acid–Changing Medicines)

Dasatinib absorption can be influenced by stomach pH. Medicines that reduce stomach acid may lower dasatinib exposure and reduce effectiveness.

• Antacids (e.g., aluminium/magnesium hydroxide): may be problematic if taken close to your dasatinib dose.
• H2 blockers (e.g., famotidine): may require timing separation from dasatinib.
• Proton pump inhibitors (PPIs) (e.g., omeprazole, esomeprazole): may significantly affect absorption.

Practical guidance:

• Tell your pharmacist if you use medicines for reflux, heartburn, or ulcers.
• Do not start or stop acid-suppressing medicines without checking with your healthcare team.
• Your clinician may adjust timing or select alternative treatments for reflux symptoms.

Alcohol and Dasatinib Interactions

There is no single universal “safe” amount of alcohol for all people taking dasatinib, because tolerance and liver function vary. However, alcohol can increase risks such as:

• Liver strain (dasatinib is metabolised in the liver and may affect liver enzymes)
• Increased dizziness, fatigue, or nausea in some patients
• Higher risk of medication side effects when combined with other drugs

Patient-friendly recommendation: If you drink alcohol, keep it moderate, avoid binge drinking, and consider discussing your typical intake with your clinician—especially if you’ve had raised liver tests or other liver-related issues.

Other Medicine Interactions (Drug–Drug Interactions)

Dasatinib is affected by medicines that influence CYP3A4 and other drug metabolism pathways, and it may also interact with medicines that affect bleeding risk or heart rhythm (QT prolongation) depending on the individual and co-medications.

Common interaction areas

• CYP3A4 inhibitors (can increase dasatinib levels): some antifungals (e.g., azoles), certain antibiotics, and other medicines may raise exposure.
• CYP3A4 inducers (can reduce dasatinib levels): certain seizure medications (antiepileptics) and some herbal products may lower effectiveness.
• Reflux/acid reducers: see “Food Interactions” section above.
• Blood thinners and antiplatelets: may increase bleeding risk, especially if platelet counts are low.
• Medicines affecting heart rhythm: if you take medicines known to affect QT interval, discuss this with your clinician.

Always check before combining medicines. Provide your pharmacist or specialist with a complete list of:

• All prescription medicines
• Over-the-counter products (including antacids and cold/flu tablets)
• Herbal supplements (including St John’s wort)

Dosing Overview (Typical Adult Approach)

Dasatinib dosing depends on the specific indication (CML vs Ph+ ALL), disease phase, prior therapy history, age, and patient response. Your treating team may reduce or adjust the dose due to side effects or blood count changes.

Common adult starting doses in clinical practice may include:

• CML chronic phase: often 100 mg once daily
• Accelerated phase or blast phase: often 140 mg once daily (or other regimens as clinically indicated)
• Ph+ ALL: dosing may vary and may be weight- or age-adjusted depending on protocols

Important: These are general examples. Your dose should follow your locally provided instructions and the current product information. If you are unsure of your dose, confirm it with your dispensing pharmacist.

Dose adjustments

• Dose reduction is commonly considered for persistent or significant adverse effects.
• Temporary interruption may be used if severe toxicity occurs.
• Ongoing blood monitoring helps guide safe continuation.

Safety Profile (What to Expect and When to Seek Help)

Like all cancer medicines, dasatinib can cause side effects. Many are manageable, but some require urgent medical attention.

Common side effects

• Fatigue
• Nausea or reduced appetite
• Diarrhoea or constipation
• Headache
• Rash or skin changes
• Muscle or joint aches
• Low blood counts (anaemia, neutropenia, or thrombocytopenia), which can increase infection or bleeding risk

Important risks to discuss promptly

• Fluid retention / pleural effusion (fluid around the lungs): may cause shortness of breath, chest tightness, or swelling.
• Bleeding (especially with low platelets): unusual bruising, nosebleeds, bleeding gums, blood in urine or stool.
• Infection risk: fever, chills, sore throat, or feeling unwell.
• Liver enzyme changes: may be detected on blood tests.
• Heart rhythm concerns in susceptible patients: palpitations, fainting, or dizziness.

Seek urgent medical help if you experience

• Severe shortness of breath, chest pain, or rapid worsening breathing
• Black/tarry stools, coughing up blood, or uncontrolled bleeding
• High fever or signs of serious infection
• Severe allergic-type reaction: swelling of face/lips, difficulty breathing, widespread rash

Monitoring is key: Regular blood tests (full blood count and liver function tests) are used to manage risk and guide dosing.

Practical Use Tips for Patients

• Use a daily reminder so doses aren’t missed.
• Keep appointments for monitoring (blood counts and chemistry tests). This is part of safe treatment, not just routine.
• Report symptoms early (breathlessness, unusual bruising, persistent diarrhoea) rather than waiting.
• Hydrate as advised and maintain nutrition, especially if nausea occurs.
• Oral care: if you develop mouth sores, use gentle mouth care and tell your clinician—some treatments for supportive care may help.
• Avoid injury if your platelet counts are low (use soft toothbrush, avoid contact sports unless approved).
• Medication list: carry an up-to-date list of your medicines, including over-the-counter products and supplements.

Alternative Options (Other Treatments for Ph+ Cancers)

Alternative options depend on your diagnosis, disease phase, previous treatments, and response. In CML and Ph+ ALL, several targeted therapies may be considered.

Potential alternatives include:

• Other TKIs used for CML and Ph+ ALL (choice depends on prior therapy and risk factors), such as imatinib, nilotinib, bosutinib, or ponatinib.
• Combination approaches in selected Ph+ ALL settings, according to specialist protocols.
• Supportive care measures to manage side effects (e.g., treatment for reflux, anti-nausea medicines, growth factor support in some cases).

Discuss with your specialist: If you have side effects or inadequate response, your clinician may consider switching within the TKI class or adjusting dose and supportive medications.

Market & Legal Context in Australia

In Australia, prescription-only medicines must be supplied according to relevant Australian regulations. Medicines for cancer treatment are generally provided under specialist supervision and with systems supporting appropriate dispensing, safety checks, and monitoring.

What this means for patients:

• Your treating doctor provides the clinically appropriate therapy plan.
• Pharmacy dispensing includes checks for interactions and correct dosing instructions.
• Ongoing monitoring helps confirm safety and efficacy.

Availability: Dasatinib tablets are supplied through regulated pharmaceutical distribution channels. Availability can depend on supply timing and stock levels for specific strengths.

Recent Guidance (How to Stay Current)

Clinical recommendations for CML and Ph+ ALL can evolve due to new evidence. In Australia, guidance is typically aligned with updates from major clinical groups and local prescribing practices, as reflected in:

• Current Australian product information
• Specialist haematology protocols
• Therapeutic guidelines for CML/ALL management

Best practice: If you’re starting or switching therapy, ask your clinician or pharmacist whether there are any recent updates relevant to your situation (for example, revised monitoring schedules or toxicity management approaches).

Delivery & Availability (Online Pharmacy Considerations in Australia)

We aim to make medicine access easier while supporting safety and correct supply.

• Stock status: Availability can vary by strength and market supply. If your exact strength is temporarily unavailable, the pharmacy team may contact you to discuss alternatives or expected restock timing.
• Packaging and temperature: Dasatinib should be stored and transported under appropriate conditions as per product instructions. Keep tablets in the original packaging.
• Delivery timeframes: Delivery time depends on location and processing schedules. Some orders may be shipped promptly, while others may require additional verification steps.

Storage: Store at room temperature in a dry place, away from heat and direct sunlight. Keep out of reach of children.

Return policies: Follow pharmacy policies for temperature-sensitive and controlled medicines. Do not return opened or used products unless instructed by the pharmacy.

FAQ (Frequently Asked Questions)

1) What is dasatinib used for?

Dasatinib is used to treat certain leukaemias, particularly those involving BCR-ABL and/or the Philadelphia chromosome (Ph+), such as CML and Ph+ ALL, depending on the patient’s disease phase and prior treatment history.

2) How is dasatinib taken each day?

It is typically taken once daily. Take it at about the same time every day. Follow your specific instructions for whether to take it with food or without food.

3) What should I do if I miss a dose?

If you miss a dose, do not double up. Contact your pharmacist or clinician for advice on how to manage missed dosing based on your schedule.

4) Can I take dasatinib with antacids or reflux medicines?

Some acid-reducing medicines may affect dasatinib absorption. Speak to your pharmacist before using antacids, H2 blockers, or PPIs. Your clinician may recommend timing adjustments or alternative medicines.

5) Are there interactions with other medicines?

Yes. Dasatinib can interact with medicines that affect liver enzymes (notably CYP3A4), as well as certain reflux medicines, blood thinners, and some heart rhythm–affecting drugs. Always provide a full list of your medicines and supplements to your pharmacist.

6) Is alcohol allowed?

Alcohol may increase risks such as liver strain and worsen side effects (like fatigue or nausea). If you choose to drink, keep it moderate and discuss your intake with your clinician—especially if you have abnormal liver tests.

7) What side effects should I watch for closely?

Report promptly: shortness of breath or chest tightness (possible fluid retention), unusual bruising or bleeding, persistent vomiting or severe diarrhoea, fever or infection symptoms, and signs of liver problems (yellowing skin/eyes, dark urine) if they occur.

8) Will I need blood tests during treatment?

Yes. Regular blood monitoring (full blood count and liver function tests) is important to track safety, guide dosing adjustments, and manage side effects.

9) Can I drive or operate machinery?

Some people experience fatigue, dizziness, or visual changes. If you feel unwell or impaired, avoid driving and risky activities. If symptoms affect you, discuss with your healthcare team.

10) Are there alternatives if I can’t tolerate dasatinib?

Alternative TKIs or different treatment strategies may be available depending on your diagnosis and response. Only your specialist can recommend a switch or adjustment.

Important Reminder

This information is designed to help patients understand dasatinib in everyday terms. Your healthcare team will tailor dosing, monitoring, and supportive care to your individual condition. If you have questions about your specific regimen, interactions, or side effects, contact your treating clinician or pharmacist.